217 related articles for article (PubMed ID: 26494790)
1. Ctr9, a key subunit of PAFc, affects global estrogen signaling and drives ERα-positive breast tumorigenesis.
Zeng H; Xu W
Genes Dev; 2015 Oct; 29(20):2153-67. PubMed ID: 26494790
[TBL] [Abstract][Full Text] [Related]
2. Systematic identification of Ctr9 regulome in ERα-positive breast cancer.
Zeng H; Lu L; Chan NT; Horswill M; Ahlquist P; Zhong X; Xu W
BMC Genomics; 2016 Nov; 17(1):902. PubMed ID: 27829357
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of Ctr9-regulated transcriptome in ERα-positive breast cancer.
Zeng H; Xu W
Genom Data; 2016 Mar; 7():103-4. PubMed ID: 26981377
[TBL] [Abstract][Full Text] [Related]
4. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
[TBL] [Abstract][Full Text] [Related]
5. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance.
Yu-Rice Y; Jin Y; Han B; Qu Y; Johnson J; Watanabe T; Cheng L; Deng N; Tanaka H; Gao B; Liu Z; Sun Z; Bose S; Giuliano AE; Cui X
Oncogene; 2016 Oct; 35(41):5400-5411. PubMed ID: 27041579
[TBL] [Abstract][Full Text] [Related]
6. Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.
Zheng ZZ; Xia L; Hu GS; Liu JY; Hu YH; Chen YJ; Peng JY; Zhang WJ; Liu W
Nucleic Acids Res; 2022 Oct; 50(18):10230-10248. PubMed ID: 36124682
[TBL] [Abstract][Full Text] [Related]
7. CTR9, a component of PAF complex, controls elongation block at the c-Fos locus via signal-dependent regulation of chromatin-bound NELF dissociation.
Yoo HS; Seo JH; Yoo JY
PLoS One; 2013; 8(4):e61055. PubMed ID: 23593388
[TBL] [Abstract][Full Text] [Related]
8. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract][Full Text] [Related]
9. Bromodomain protein BRD4 is required for estrogen receptor-dependent enhancer activation and gene transcription.
Nagarajan S; Hossan T; Alawi M; Najafova Z; Indenbirken D; Bedi U; Taipaleenmäki H; Ben-Batalla I; Scheller M; Loges S; Knapp S; Hesse E; Chiang CM; Grundhoff A; Johnsen SA
Cell Rep; 2014 Jul; 8(2):460-9. PubMed ID: 25017071
[TBL] [Abstract][Full Text] [Related]
10. Acetylation of histone H3K27 signals the transcriptional elongation for estrogen receptor alpha.
Gao Y; Chen L; Han Y; Wu F; Yang WS; Zhang Z; Huo T; Zhu Y; Yu C; Kim H; Lee M; Tang Z; Phillips K; He B; Jung SY; Song Y; Zhu B; Xu RM; Feng Q
Commun Biol; 2020 Apr; 3(1):165. PubMed ID: 32265480
[TBL] [Abstract][Full Text] [Related]
11. Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions.
Wen J; Li R; Lu Y; Shupnik MA
Oncogene; 2009 Jan; 28(4):575-86. PubMed ID: 18997820
[TBL] [Abstract][Full Text] [Related]
12. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
13. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.
Légaré S; Cavallone L; Mamo A; Chabot C; Sirois I; Magliocco A; Klimowicz A; Tonin PN; Buchanan M; Keilty D; Hassan S; Laperrière D; Mader S; Aleynikova O; Basik M
Cancer Res; 2015 Oct; 75(20):4351-63. PubMed ID: 26297734
[TBL] [Abstract][Full Text] [Related]
14. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.
Aiyar SE; Sun JL; Blair AL; Moskaluk CA; Lu YZ; Ye QN; Yamaguchi Y; Mukherjee A; Ren DM; Handa H; Li R
Genes Dev; 2004 Sep; 18(17):2134-46. PubMed ID: 15342491
[TBL] [Abstract][Full Text] [Related]
16. p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen receptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells.
Zhuang T; Zhu J; Li Z; Lorent J; Zhao C; Dahlman-Wright K; Strömblad S
Oncotarget; 2015 Dec; 6(41):43853-68. PubMed ID: 26554417
[TBL] [Abstract][Full Text] [Related]
17. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
18. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
19. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
